tiprankstipranks
Advertisement
Advertisement

XERS Stock Latest News

Xeris Biopharma Eliminates 2028 Convertible Notes Via Exchanges
Company AnnouncementsXeris Biopharma Eliminates 2028 Convertible Notes Via Exchanges
6d ago
8K
XERS
Xeris Pharmaceuticals appoints new director and board chair
PremiumCompany Announcements
Xeris Pharmaceuticals appoints new director and board chair
23d ago
8K
XERS
Xeris Biopharma appoints CEO John Shannon as chair of the board
PremiumThe Fly
Xeris Biopharma appoints CEO John Shannon as chair of the board
23d ago
XERS
Xeris Biopharma announces notice of allowance from USPTO for Keveyis patent
PremiumThe Fly
Xeris Biopharma announces notice of allowance from USPTO for Keveyis patent
1M ago
XERS
Xeris Biopharma Announces Debt Reduction via Note Exchanges
PremiumCompany Announcements
Xeris Biopharma Announces Debt Reduction via Note Exchanges
1M ago
8K
XERS
Xeris Biopharma announces private exchange of convertible notes
PremiumThe FlyXeris Biopharma announces private exchange of convertible notes
1M ago
XERS
Xeris Biopharma Shareholders Elect Directors and Ratify Auditor
Premium
Company Announcements
Xeris Biopharma Shareholders Elect Directors and Ratify Auditor
2M ago
8K
XERS
Xeris Pharmaceuticals Signals Profitable Growth Acceleration
Premium
Company Announcements
Xeris Pharmaceuticals Signals Profitable Growth Acceleration
3M ago
XERS
Xeris Biopharma reports Q1 EPS 1c, consensus 0c
PremiumThe Fly
Xeris Biopharma reports Q1 EPS 1c, consensus 0c
3M ago
XERS
Xeris Biopharma Announces Board Transition as Director Retires
PremiumCompany Announcements
Xeris Biopharma Announces Board Transition as Director Retires
3M ago
8K
XERS
Xeris Pharmaceuticals Earnings Call Highlights Rapid Growth
PremiumCompany Announcements
Xeris Pharmaceuticals Earnings Call Highlights Rapid Growth
5M ago
XERS
Nasus Approaches Key Data Readout That Could Reshape the Multi Billion Dollar Epinephrine Market (NYSE: NSRX)
PremiumTipRanks Newswire
Nasus Approaches Key Data Readout That Could Reshape the Multi Billion Dollar Epinephrine Market (NYSE: NSRX)
5M ago
NSRX
XERS
Xeris Biopharma reports Q4 revenue 6c vs. (3c) last year
PremiumThe FlyXeris Biopharma reports Q4 revenue 6c vs. (3c) last year
5M ago
XERS
Xeris Biopharma sees FY26 revenue $375M-$390M, consensus $368M
Premium
The Fly
Xeris Biopharma sees FY26 revenue $375M-$390M, consensus $368M
5M ago
XERS
Xeris Pharmaceuticals (XERS) Q4 Earnings Cheat Sheet
Premium
Pre-Earnings
Xeris Pharmaceuticals (XERS) Q4 Earnings Cheat Sheet
5M ago
XERS
Xeris Biopharma subsidiaries file Recorlev patent infringement lawsuit
PremiumThe Fly
Xeris Biopharma subsidiaries file Recorlev patent infringement lawsuit
5M ago
XERS
TheStreet Pro: Four Stocks that Will Win Despite “Irrational Panic” over AI
PremiumMarket News
TheStreet Pro: Four Stocks that Will Win Despite “Irrational Panic” over AI
5M ago
COF
VIR
Xeris Biopharma: Strong 2025 Outperformance and Underappreciated Multiyear Growth Drive Buy Rating
PremiumRatings
Xeris Biopharma: Strong 2025 Outperformance and Underappreciated Multiyear Growth Drive Buy Rating
7M ago
XERS
Xeris Biopharma initiated with an Overweight at Barclays
PremiumThe Fly
Xeris Biopharma initiated with an Overweight at Barclays
8M ago
XERS
Xeris Pharmaceuticals Secures Patent Allowance for XP-8121
PremiumCompany AnnouncementsXeris Pharmaceuticals Secures Patent Allowance for XP-8121
8M ago
8K
XERS
Xeris Biopharma issued notice of allowance from USPTO for XP-8121
Premium
The Fly
Xeris Biopharma issued notice of allowance from USPTO for XP-8121
8M ago
XERS
Xeris Biopharma price target raised to $8 from $6 at Piper Sandler
Premium
The Fly
Xeris Biopharma price target raised to $8 from $6 at Piper Sandler
9M ago
XERS

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >